Officer: Government ensured speedier manufacture of Covid vaccine : The Tribune India

Join Whatsapp Channel

Officer: Government ensured speedier manufacture of Covid vaccine

Says currently, 12 under clinical trial, 18 under preclinical testing

Officer: Government ensured speedier manufacture of Covid vaccine

Dr S Eswara Reddy, Joint Drugs Controller General of India, Central Drugs Standards Control Organisation (middle), and Dr Arun Bhardwaj, Director, Central Drugs Lab, Kasauli, in Kasauli on Thursday.



Ambika Sharma

Tribune News Service

Kasauli, November 25

A slew of measures were reportedly taken during the pandemic to speed up vaccine production without compromising on the quality.

Dr S Eswara Reddy, Joint Drugs Controller General of India, Central Drugs Standards Control Organisation (CDSCO), who was here to address a Ministry of Health and Family Welfare’s knowledge-sharing workshop with mediapersons today, said these measures included accelerated review of vaccine dossiers, frequent subject expert committee (SEC) meetings, rolling review, waiver of bridging trails, besides notification of additional labs for testing, which helped speed up clearances without compromising the quality of vaccines.

Additional measures such as stockpiling of vaccines under clinical trials, parallel testing and handholding the manufacturers to enhance production, import of raw materials and other clearances were also put in place to facilitate speedier manufacturing of Covid vaccines by the CDSCO.

“As many as 12 vaccines are under clinical trials, while 18 are under preclinical testing and development, which includes three vaccines under clinical trial in the children’s age group,” said Dr Reddy, adding that India had huge capacity to manufacture vaccines.

Elaborating on other key measures, he said: “Manpower has been enhanced multiple times in the last one decade — both in the regular and contractual category — in the CDSCO, given its expanding role and requirement. Appointing 465 inspectors and other regulatory staff for medical device regulation was under active consideration of the ministry as it was an emerging area of concern.”

Dr Dimple Kasana, Director, Central Research Institute, said the institute had initiated the development of therapeutic antisera for Covid-19 in collaboration with ICMR-National Institute of Virology and an ICMR-approved Covid testing lab was set up in 2020.

She said the DPT vaccine manufactured in the new C-Good Manufacturing Practices lab was for the universal immunisation programme since 2020.


Top News

63% voting in 2nd phase, highest 79.46% in Tripura

63% voting in 2nd phase, highest 79.46% in Tripura

Jammu sees 71.91% turnout | Lowest 54.85% in UP

SC’s thumbs up to EVMs, junks PILs seeking return of paper ballot system

SC’s thumbs up to EVMs, junks PILs seeking return of paper ballot system

Rejects demand for verifying 100% votes with VVPAT slips

Lok Sabha election 2024: Voting under way in 88 constituencies; Rahul Gandhi, Hema Malini in fray

Over 63 per cent turnout in Phase 2 of Lok Sabha polls; Tripura records 79.46 per cent, Manipur 77.32 Over 63 per cent turnout in Phase 2 of Lok Sabha polls; Tripura records 79.46 per cent, Manipur 77.32

The Election Commission says polling remained largely peacef...

Arvind Kejriwal as CM even after arrest puts political interest over national interest: Delhi High Court

Arvind Kejriwal as CM even after arrest puts political interest over national interest: Delhi High Court

The court says the Delhi government is ‘interested in approp...

Amritpal Singh to contest Lok Sabha poll from Punjab’s Khadoor Sahib, confirms mother

Amritpal Singh to contest Lok Sabha poll from Punjab’s Khadoor Sahib, confirms mother

The formal announcement is made by his mother Balwinder Kaur...


Cities

View All